Cosmos Health CEO Greg Siokas Issues Letter to Shareholders Highlighting Record 2026 Revenue, U.S. Subscription Growth and Global Expansion
Key Highlights
- ➤Nine-month revenue approximately $54.3 million, up 19% year over year
- ➤Full-year 2026 revenue guidance reaffirmed above $90 million
- ➤U.S. subscriptions reached 8,940, up 42% in five days
- ➤U.S. fourth-quarter revenue expected approximately $15 million at 70% gross margin
- ➤Cana contract manufacturing pipeline exceeded 32.7 million units, up sixfold
- ➤Fiscal 2029 guidance targets $200.6 million revenue and $44.2 million adjusted EBITDA
Expert Statements
Greg Siokas, CEO of Cosmos Health
“2026 marks a defining moment in the evolution of Cosmos Health.”
Greg Siokas, CEO of Cosmos Health
“For years, we have invested in pharmaceutical manufacturing, automated distribution, proprietary brands, technology and international expansion to build a vertically integrated global healthcare platform.”
Greg Siokas, CEO of Cosmos Health
“Today, those investments are converging.”
Greg Siokas, CEO of Cosmos Health
“Our established businesses are operating at record levels, our proprietary brands are sold in more than 40 countries, our contract manufacturing pipeline has expanded sixfold since mid-2024, and our recently launched U.S. direct-to-consumer business is adding a new source of higher-margin, recurring revenue.”
Greg Siokas, CEO of Cosmos Health
“We have achieved this amid global uncertainty and geopolitical instability.”
Greg Siokas, CEO of Cosmos Health
“Our preliminary nine-month revenue of approximately $54.3 million, up 19% year over year, reflects that progress, and we reaffirm our expectation that full-year 2026 revenue will surpass $90 million.”
Greg Siokas, CEO of Cosmos Health
“Yet revenue growth alone does not define our ambition.”
Greg Siokas, CEO of Cosmos Health
“Our focus is on improving the quality of our revenue, broadening recurring customer relationships, expanding gross margins and moving toward sustainable profitability.”
CHICAGO, IL / ACCESS Newswire / October 20, 2026 / Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that its Chief Executive Officer, Greg Siokas, has issued the following letter to the Company's shareholders, providing a 2026 business update.
2026 marks a defining moment in the evolution of Cosmos Health. For years, we have invested in pharmaceutical manufacturing, automated distribution, proprietary brands, technology and international expansion to build a vertically integrated global healthcare platform. Today, those investments are converging. Our established businesses are operating at record levels, our proprietary brands are sold in more than 40 countries, our contract manufacturing pipeline has expanded sixfold since mid-2024, and our recently launched U.S. direct-to-consumer business is adding a new source of higher-margin, recurring revenue. We have achieved this amid global uncertainty and geopolitical instability.
Get started
Create a free account to read the full story.